What is Lofta?
Lofta operates at the intersection of medical device distribution and patient-centric digital health. The company provides a comprehensive ecosystem for sleep apnea management, streamlining the path from diagnosis to long-term therapy. By offering home sleep apnea testing alongside a curated selection of CPAP machines, masks, and travel-optimized accessories, Lofta addresses critical pain points in patient adherence and accessibility. Their business model leverages expert clinical guidance and competitive pricing to serve both individual patients and healthcare providers, positioning the firm as a key player in the home-based respiratory care market.
How much funding has Lofta raised?
Lofta has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Lofta
PPP
Public-Private Partnership
What's next for Lofta?
With this late-stage financing, Lofta is well-positioned to accelerate its market penetration and enhance its technological infrastructure. The strategic allocation of this capital will likely focus on expanding the company's digital monitoring capabilities and optimizing its supply chain to meet the growing demand for remote patient management solutions. As the healthcare industry shifts toward decentralized care models, Lofta's ability to integrate diagnostic testing with ongoing therapeutic support provides a robust foundation for sustained growth. Future initiatives will likely prioritize the scaling of their patient support services and the integration of advanced data analytics to further improve treatment outcomes for individuals suffering from sleep-disordered breathing.
See full Lofta company page
